|
Pronunciation |
|
(SOW
dee um SIT rate & poe TASS ee
um SIT rate MIKS chur) |
|
|
U.S. Brand
Names |
|
Polycitra® |
|
|
Generic
Available |
|
Yes |
|
|
Pharmacological Index |
|
Alkalinizing Agent |
|
|
Use |
|
Conditions where long-term maintenance of an alkaline urine is desirable as
in control and dissolution of uric acid and cystine calculi of the urinary
tract |
|
|
Pregnancy Risk
Factor |
|
Not established |
|
|
Usual Dosage |
|
Oral:
Adults: 15-30 mL diluted in water after meals and at bedtime
|
|
|
Dietary
Considerations |
|
Should be administered after meals |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Palatability is improved by chilling solution, dilute each dose with 1-3 oz
of water and follow with additional water; take after meals to prevent saline
laxative effect |
|
|
Nursing
Implications |
|
Dilute each dose in 30-90 mL of water prior to
administration |
|
|
Dosage Forms |
|
Syrup: Sodium citrate 500 mg, potassium citrate 550 mg, with citric acid 334
mg per 5 mL [sodium 1 mEq, potassium 1 mEq, bicarbonate 2
mEq] |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|